These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Rapid screening and quantitative detection of 11 illegally added antidiabetics in health care products by ultra performance liquid chromatography-quadrupole/electrostatic field orbitrap high resolution mass spectrometry].
    Author: Du Y, Li Q, Wu C, Zhang Y.
    Journal: Se Pu; 2015 Apr; 33(4):371-6. PubMed ID: 26292406.
    Abstract:
    A method for rapid screening and quantification of 11 antidiabetics (nateglinide, pioglitazone hydrochloride, gliquidone, gliclazide, glipizide, glibenclamide, metformin hydrochloride, repaglinide, phenformin hydrochloride, rosiglitazone hydrochloride, glimepiride) illegally added in health care products by ultra performance liquid chromatography (UPLC)-quadrupole/ electrostatic field orbitrap mass spectrometry was established. The samples were extracted with methanol, and separated on an Agilent Poroshell 120 SB-C18 column (100 mm x 4.6 mm, 2.7 µm) with acetonitrile-10 mmol/L ammonium acetate solution as mobile phases by gradient elution. The positive mode was used in the MS detection. The resolution of the precursor mass was 70,000, while the resolution of the product mass was 17,500. The results indicated that the linearity of all the 11 antidiabetics ranged from 0.005 mg/L to 0.5 mg/L with the correlation coefficients greater than 0.99. The limits of detection were confirmed by spiked samples, and were between 2.7 and 5.1 µg/kg for the 11 antidiabetics. The recoveries were in the range of 87.3% to 98.3%, with the relative standard deviations in the range of 2.18%-5.21%. This method is accurate, simple and rapid, and can be used in rapid screening and quantitative analysis of the 11 illegally added antidiabetics in health care products.
    [Abstract] [Full Text] [Related] [New Search]